Osmotic Diuretics Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Osmotic Diuretics. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Osmotic Diuretics Indian Medical PG Question 1: In patient of head injuries with rapidly increasing intracranial tension without hematoma, the drug of choice for initial management would be :
- A. 20% Mannitol (Correct Answer)
- B. Lasix
- C. Glycine
- D. Steroids
Osmotic Diuretics Explanation: ***20% Mannitol***
- **Mannitol** is an osmotic diuretic that reduces **intracranial pressure (ICP)** by creating an osmotic gradient, drawing water from the brain parenchyma into the intravascular space [1].
- Its rapid onset of action and significant ICP-reducing effects make it the drug of choice for acute management of elevated ICP in head injuries without hematoma.
*Lasix*
- **Furosemide (Lasix)** is a loop diuretic that can reduce ICP by decreasing cerebrospinal fluid production and promoting diuresis.
- However, its effects are generally slower and less potent than mannitol for acute, rapidly increasing ICP.
*Glycine*
- **Glycine** is an amino acid and neurotransmitter; it has no direct role in the acute management of increased ICP.
- It is sometimes used as an irrigating solution in urological procedures but is not indicated for brain injury.
*Steroids*
- **Steroids**, particularly **dexamethasone**, are effective in reducing vasogenic edema associated with brain tumors or abscesses.
- They are generally **not recommended** for acute traumatic brain injury due to lack of benefit and potential for increased mortality or complications.
Osmotic Diuretics Indian Medical PG Question 2: A 25 -year-old male presented to the emergency department with head trauma due to a road traffic accident. In the hospital, the patient developed seizures, and an emergency CT scan revealed widespread cerebral edema. Which of the following is the diuretic of choice for cerebral edema in this patient?
- A. A. Mannitol (Correct Answer)
- B. B. Spironolactone
- C. C. Furosemide
- D. D. Hydrochlorothiazide
- E. E. Acetazolamide
Osmotic Diuretics Explanation: ***Mannitol***
- **Mannitol** is an osmotic diuretic that creates an osmotic gradient, drawing water from the brain parenchyma into the intravascular space, thereby reducing **cerebral edema**.
- Its rapid onset of action and ability to cross an intact blood-brain barrier sparingly makes it the drug of choice for acute management of elevated intracranial pressure due to **cerebral edema**.
*Spironolactone*
- **Spironolactone** is a potassium-sparing diuretic that primarily acts on the distal tubules to inhibit aldosterone, leading to sodium and water excretion.
- It is unsuitable for acute cerebral edema as its diuretic effect is too slow and it does not create the necessary osmotic gradient.
*Furosemide*
- **Furosemide** is a loop diuretic that inhibits sodium-potassium-chloride co-transporter in the loop of Henle, leading to significant diuresis.
- While it can remove fluid, it does not create the same osmotic gradient as mannitol and is less effective at rapidly reducing **intracranial pressure** directly related to cerebral edema.
*Hydrochlorothiazide*
- **Hydrochlorothiazide** is a thiazide diuretic that primarily acts on the distal convoluted tubule to inhibit sodium reabsorption.
- Its diuretic action is too slow and relatively mild for the acute management of severe conditions like **cerebral edema**.
*Acetazolamide*
- **Acetazolamide** is a carbonic anhydrase inhibitor that reduces CSF production and has a role in chronic management of idiopathic intracranial hypertension.
- However, it is not suitable for acute cerebral edema following trauma as its onset is too slow and its diuretic effect is relatively weak compared to osmotic diuretics.
Osmotic Diuretics Indian Medical PG Question 3: Which of the following diuretics can lead to erectile dysfunction?
- A. Thiazide diuretics (Correct Answer)
- B. Carbonic anhydrase inhibitor
- C. Loop diuretics
- D. Mannitol
Osmotic Diuretics Explanation: ***Thiazide diuretics***
- **Thiazide diuretics** can cause **erectile dysfunction**, possibly due to effects on vascular function and **reduced blood flow** to the penis.
- This adverse effect is a known concern and can impact patient adherence to **antihypertensive therapy**.
*Carbonic anhydrase inhibitor*
- **Carbonic anhydrase inhibitors** like acetazolamide are primarily used for glaucoma, altitude sickness, and metabolic alkalosis, and do not typically cause **erectile dysfunction**.
- Their primary side effects relate to **metabolic acidosis** and electrolyte imbalances, not sexual function.
*Loop diuretics*
- **Loop diuretics** like furosemide are potent diuretics used in conditions like heart failure and edema; **erectile dysfunction** is not a common or significant side effect.
- Their main adverse effects include **hypokalemia**, ototoxicity, and hypovolemia.
*Mannitol*
- **Mannitol** is an osmotic diuretic used to reduce intracranial and intraocular pressure.
- It is administered intravenously and its side effects primarily involve **fluid and electrolyte disturbances**, not **erectile dysfunction**.
Osmotic Diuretics Indian Medical PG Question 4: The Loop diuretic acts at
- A. Ascending loop (Correct Answer)
- B. PCT
- C. DCT
- D. Descending loop
Osmotic Diuretics Explanation: ***Ascending loop***
- Loop diuretics, such as **furosemide**, inhibit the **Na-K-2Cl cotransporter** in the **thick ascending limb of the loop of Henle**.
- This action prevents the reabsorption of sodium, potassium, and chloride, leading to increased excretion of water.
*PCT*
- The **proximal convoluted tubule (PCT)** is primarily involved in the reabsorption of most filtered solutes like glucose, amino acids, and bicarbonate.
- While carbonic anhydrase inhibitors act here, loop diuretics do not exert their main effect in the PCT.
*DCT*
- The **distal convoluted tubule (DCT)** is where thiazide diuretics primarily act by inhibiting the **Na-Cl cotransporter**.
- Loop diuretics have no significant effect on electrolyte handling in the DCT.
*Descending loop*
- The **descending loop of Henle** is mainly permeable to **water** and impermeable to solutes.
- Its function is to concentrate the urine, but it is not a primary site of action for loop diuretics.
Osmotic Diuretics Indian Medical PG Question 5: All the following adverse effects can be caused by Loop Diuretics EXCEPT -
- A. Hypomagnesemia
- B. Hypercalcemia (Correct Answer)
- C. Hyperuricemia
- D. Hyperglycemia
Osmotic Diuretics Explanation: ***Hypercalcemia***
- Loop diuretics inhibit the reabsorption of calcium in the thick ascending limb of the loop of Henle, leading to **increased urinary calcium excretion** and, consequently, **hypocalcemia** [2], [3].
- Therefore, loop diuretics actively decrease calcium levels, so hypercalcemia is not an adverse effect.
*Hypomagnesemia*
- Loop diuretics interfere with magnesium reabsorption in the thick ascending limb, which can lead to **increased urinary excretion of magnesium** and subsequently cause **hypomagnesemia** [1], [2].
- This effect is clinically significant as it can exacerbate other electrolyte imbalances or cause symptoms like muscle weakness or arrhythmias.
*Hyperuricemia*
- Loop diuretics can lead to **hyperuricemia** by competing with uric acid for secretion into the renal tubule and by increasing its reabsorption, thereby decreasing its excretion [1].
- This can precipitate or worsen gout, especially in susceptible individuals [1].
*Hyperglycemia*
- Loop diuretics, like thiazide diuretics, can cause **hyperglycemia** by impairing insulin secretion and increasing peripheral insulin resistance.
- This effect is more pronounced with higher doses and prolonged use, potentially worsening glycemic control in diabetic patients or unmasking latent diabetes.
Osmotic Diuretics Indian Medical PG Question 6: Thiazides and loop diuretics both have opposite action on which of the following ions ?
- A. Potassium
- B. Sodium
- C. Chloride
- D. Calcium (Correct Answer)
Osmotic Diuretics Explanation: ***Calcium***
- Thiazide diuretics **increase calcium reabsorption** in the distal convoluted tubule, leading to decreased urinary calcium excretion.
- Loop diuretics **decrease calcium reabsorption** in the thick ascending limb of the loop of Henle, resulting in increased urinary calcium excretion.
*Potassium*
- Both thiazide and loop diuretics can cause **hypokalemia** by increasing potassium excretion in the urine.
- This is due to increased sodium delivery to the collecting duct, which stimulates potassium secretion.
*Sodium*
- Both thiazide and loop diuretics inhibit sodium reabsorption at different sites in the nephron, leading to **increased urinary sodium excretion** (natriuresis).
- This is their primary mechanism of action for diuresis.
*Chloride*
- Both thiazide and loop diuretics inhibit **chloride reabsorption** as they block specific sodium-chloride cotransporters.
- Thiazides inhibit the Na-Cl cotransporter in the DCT, while loop diuretics inhibit the Na-K-2Cl cotransporter in the thick ascending limb.
Osmotic Diuretics Indian Medical PG Question 7: Potassium-sparing diuretics act at the level of
- A. Carbonic anhydrase
- B. Aldosterone receptor (Correct Answer)
- C. NaCl symporter
- D. Na-K pump
Osmotic Diuretics Explanation: ***Aldosterone receptor***
- **Potassium-sparing diuretics** include two main classes:
1. **Aldosterone receptor antagonists** (e.g., **spironolactone**, **eplerenone**) that act on **aldosterone receptors** in the collecting tubules
2. **ENaC blockers** (e.g., **amiloride**, **triamterene**) that directly block **epithelial sodium channels (ENaC)** in the collecting duct
- Both mechanisms reduce **sodium reabsorption** and **potassium secretion** in the **collecting tubule**, leading to retained potassium.
- The aldosterone receptor is the most commonly tested site for this drug class.
*Carbonic anhydrase*
- **Carbonic anhydrase inhibitors** (e.g., **acetazolamide**) act primarily in the **proximal convoluted tubule**.
- They inhibit **bicarbonate reabsorption**, leading to diuresis and metabolic acidosis, and are not considered potassium-sparing.
*NaCl symporter*
- **Thiazide diuretics** act on the **NaCl symporter (NCC)** in the **distal convoluted tubule**.
- They inhibit sodium and chloride reabsorption but do not spare potassium; chronic use can lead to **hypokalemia**.
*Na-K pump*
- The **Na-K pump** (Na+/K+-ATPase) is found in many cells and maintains ion gradients, but it is not the primary target of potassium-sparing diuretics.
- While involved in renal transport, diuretics targeting this pump have different primary mechanisms and therapeutic uses.
Osmotic Diuretics Indian Medical PG Question 8: A 39-year-old man is undergoing resuscitation with blood products for an upper GI bleed. He is suspected of having a hemolytic transfusion reaction. Which of the following is appropriate in the management of this patient?
- A. Fluids and mannitol (Correct Answer)
- B. Removal of nonessential foreign body irritants, for example, Foley catheter
- C. 0.1 M HCl infusion
- D. Fluid restriction
Osmotic Diuretics Explanation: ***Fluids and mannitol***
- **Aggressive intravenous fluids** are crucial to maintain renal perfusion and prevent acute kidney injury by flushing out free hemoglobin [1].
- **Mannitol** is an osmotic diuretic that promotes renal excretion of hemoglobin and prevents tubular obstruction; it should be used cautiously to avoid fluid overload [1].
*Removal of nonessential foreign body irritants, for example, Foley catheter*
- While **infection control** is generally important, removing a Foley catheter is not a primary or direct intervention for managing a **hemolytic transfusion reaction**.
- A Foley catheter actually assists in monitoring **urine output**, which is critical for assessing renal function during a hemolytic transfusion reaction [1].
*0.1 M HCl infusion*
- **Hydrochloric acid (HCl) infusion** would cause severe **acidosis** and is not indicated in the management of a hemolytic transfusion reaction.
- The focus is on **maintaining blood pressure**, **renal perfusion**, and addressing potential **coagulopathy**, not altering systemic pH with strong acids.
*Fluid restriction*
- **Fluid restriction** would be detrimental in a patient with a hemolytic transfusion reaction, as it can worsen **hypovolemia**, **renal hypoperfusion**, and accelerate acute kidney injury.
- **Aggressive fluid hydration** is essential to help excrete hemolyzed products and maintain kidney function [1].
Osmotic Diuretics Indian Medical PG Question 9: A diabetic patient with history of heart failure is prescribed pioglitazone. What complication may arise?
- A. Hepatotoxicity
- B. Pulmonary fibrosis
- C. Fluid retention (Correct Answer)
- D. Hypokalemia
Osmotic Diuretics Explanation: ***Fluid retention***- **Pioglitazone**, a thiazolidinedione (TZD), commonly causes **fluid retention** or edema [1].- This fluid retention can **exacerbate heart failure** symptoms and lead to cardiac decompensation, especially in patients with pre-existing heart conditions [1].*Hepatotoxicity*- While TZDs like pioglitazone have been associated with **liver dysfunction** in some cases, significant hepatotoxicity is rare and usually not the primary concern or most common serious side effect [1].- **Regular monitoring of liver enzymes** is recommended, but fluid retention leading to heart failure exacerbation is a more immediate and severe risk in this patient profile.*Pulmonary fibrosis*- **Pulmonary fibrosis** is not a known or common complication directly associated with pioglitazone use.- This complication is typically linked to other medications or systemic diseases.*Hypokalemia*- **Hypokalemia**, or low potassium levels, is generally not a direct side effect of pioglitazone.- Electrolyte imbalances associated with heart failure or diuretic use, rather than pioglitazone itself, are more likely causes of hypokalemia.
Osmotic Diuretics Indian Medical PG Question 10: Which of the following potassium-sparing diuretics was the first to be shown to reduce cardiac mortality in chronic heart failure patients?
- A. Spironolactone (Correct Answer)
- B. Amiloride
- C. Triamterene
- D. Eplerenone
Osmotic Diuretics Explanation: ***Spironolactone***
- **Spironolactone** was the first potassium-sparing diuretic shown to reduce **cardiac mortality** in patients with **chronic heart failure** in the **RALES trial** (Randomized Aldactone Evaluation Study).
- Its beneficial effects in heart failure are primarily attributed to its **aldosterone receptor antagonist** properties, which counteract the harmful effects of aldosterone on the myocardium and vasculature, rather than just its diuretic effect.
*Amiloride*
- **Amiloride** is a potassium-sparing diuretic that works by directly inhibiting **epithelial sodium channels (ENaC)** in the collecting duct.
- While it helps in potassium conservation, it has not been shown to significantly reduce cardiac mortality in chronic heart failure patients in clinical trials.
*Triamterene*
- **Triamterene** is another potassium-sparing diuretic that also directly inhibits **ENaC** in the collecting duct, similar to amiloride.
- Like amiloride, it is used to prevent hypokalemia but lacks evidence for significant **cardiac mortality reduction** in chronic heart failure.
*Eplerenone*
- **Eplerenone** is a selective **aldosterone receptor antagonist**, similar to spironolactone, with fewer hormonal side effects.
- While it has been shown to reduce **cardiac mortality** in chronic heart failure (e.g., in the EMPHASIS-HF trial), it was introduced later than spironolactone and was not the *first* to demonstrate this benefit.
More Osmotic Diuretics Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
